Innometry Co. Ltd (302430) fair value: what the stock is really worth
As of Sep 23, 2026: fair value of Innometry Co. Ltd KRW 6,526, price KRW 7,160, upside -8.9%, quality 52 out of 100. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.
Watch Innometry Co. Ltd for free, get notified when fair value or trend changes. Plus fair value for all 35,000+ stocks, 14 days of Pro free, no card.Watch for freePro now: $1 first month
Innometry Co., Ltd. manufactures and sells X-ray inspection systems in South Korea. EV battery inspection solution, industrial non-destructive testing Solution, semiconductor inspection solution, stacking manufacturing equipment for EV battery, and AI image processing products and solutions.
Show more
Innometry Co., Ltd. manufactures and sells X-ray inspection systems in South Korea. EV battery inspection solution, industrial non-destructive testing Solution, semiconductor inspection solution, stacking manufacturing equipment for EV battery, and AI image processing products and solutions. The company was founded in 2008 and is headquartered in Hwaseong-si, South Korea.
Stock analysis
Innometry Co. Ltd (302430) currently trades at 7,160 KRW, while our model-based Fair Value estimate is 6,526 KRW, implying the stock looks roughly 9.7% fairly valued today.
Show more
Valuation
Bull case: the DCF Models group reads highest at a median of 7,028 KRW per share, and 2 of the 7 models we run sit above the 7,160 KRW price.
Bear case: the Asset-Based group reads lowest at 4,060 KRW, and 5 of the 7 models stay below the price. Evidence for this calculation is low.
Scenario range: 4,799 KRW (bear) to 8,803 KRW (bull), the price of 7,160 KRW sits inside it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 52/100 (solid quality), in the Industrials sector.
Weak Growth: Revenue growth is inconsistent: the periods point in different directions, so there is no trend to rely on.
Innometry Co. Ltd reported revenue of 38.6B KRW in FY2025 versus 46.5B KRW in FY2021, a compound −4.6%/yr. Reported net income was −4.3B KRW in FY2025.
Key figures
Market cap 70.4B KRW (≈ $51.7M) · P/S ratio 1.18 · Net margin −11.1% · Return on equity −1.8% · Return on assets (EBIT) 0.3% · Operating margin 1.4% · Revenue (TTM) 47.4B KRW · Revenue growth (YoY) +102%.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 42 out of 100 (low confidence).
What moves the price
The share trades about 33% below its 52-week high and 70% above its 52-week low, currently below its 200-day average.
For context, the median of 10 Industrials peers we cover trades at −50% fair-value upside, at −9%, 302430 screens cheaper than that median.
Fair Value models
Bear 4,799 KRWFair Value 6,526 KRWBull 8,803 KRW
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above is their evidence-weighted blend, not the output of a single model.Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target.Evidence ⓘEvidence = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card.40/100
Revenue growth is inconsistent: the periods point in different directions, so there is no trend to rely on.
Revenue growth 1 year
−27.2%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
−20.1%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+13.2%
Start year 2020 (pandemic)
Revenue growth 9 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+10.1%
’16
’17
’18
’19
’20
’21
’22
’23
’24
’25
Profit margin (trend) ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.
−21.4% (2020) → −14.8% (2025)
What shareholders gained per year ⓘWe only publish this rate when it is defensible. Reason: fiscal 2025 is a loss year, no rate is defined from a loss
not computed
Growth Forecast
Little optimism in the price
The price assumes less growth than the company has delivered so far.
What the price assumes ⓘThis turns our valuation around: instead of asking what the share is worth, it asks what growth the current price requires. It uses the cash the company keeps after all spending (free cash flow), the same discount rate as our models, five years of growth, then slowing evenly to 2 % a year by year ten. Compared with the analysts' sales forecasts extended to the same five years (at least three analysts, for context only, it does not enter the Fair Value): within 3 percentage points counts as "in line" (amber), below that little optimism (green), above that a lot of optimism (red).
+0.5%
Yearly growth needed for the next five years to justify today's price.
What forecasts expect
n/a
No analyst forecast available.
After inflation (South Korea: IMF forecast 2.1% a year to 2030, 2.1% from 2016 to 2025) that is about −1.6% a year for the price.
Price, fair value, quality and upside side by side.
Free, no sign-up
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Specialty Industrial Machinery · 827 stocks
Beats the industry median on 3/7 measures
A mixed picture versus its industry peers.
Valuation
Quality Score52 · Below median
Fair Value upside−9% · Above median
Profitability
Return on assets−3% · Bottom 25%
Net margin (TTM)−2% · Bottom 25%
Operating margin (TTM)1% · Bottom 25%
Growth and dividend
Revenue growth102% · Top 25%
Valuation Multiplesvs Specialty Industrial Machinery median · lower = cheaper
For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.
Is Innometry Co. Ltd (302430) overvalued or undervalued?
As of Sep 24, 2026, our model estimates a fair value of 6,526 KRW versus a price of 7,160 KRW, about −9% upside (fairly valued).
What is the fair value of 302430?
Our model-based fair value for Innometry Co. Ltd is 6,526 KRW (as of Sep 24, 2026), built from audited fundamentals. The current price: 7,160 KRW.
What is the quality score of 302430?
Innometry Co. Ltd has a Quality Score of 52/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Innometry Co. Ltd (302430)?
Our model-based price target is the fair value of 6,526 KRW (as of Sep 24, 2026) from 7 valuation models. Cautious scenario 4,799 KRW, optimistic scenario 8,803 KRW. It is a calculation from audited fundamentals, not an analyst target.
What is the Innometry Co. Ltd stock forecast for 2026?
Our models put fair value at 6,526 KRW, about −9% upside versus a price of 7,160 KRW (fairly valued). Cautious scenario 4,799 KRW, optimistic scenario 8,803 KRW. The calculation is refreshed regularly with new filings.
What is the revenue of Innometry Co. Ltd (302430)?
Innometry Co. Ltd reported trailing-twelve-month revenue of about 47.4B KRW (latest available figure, as of Sep 24, 2026).
What growth is priced into Innometry Co. Ltd (302430)?
For today's price to be fair in a discounted-cash-flow model, Innometry Co. Ltd would have to grow free cash flow by +0.5 % per year for five years (discount rate 11.2 %, then slowing evenly to 2 % perpetual growth by year ten). Over the last 5 years revenue grew +13.2 % per year. As of Sep 24, 2026.
What discount rate (WACC) does the fair value of 302430 use?
Our models discount Innometry Co. Ltd at 11.2 %: a base by market capitalisation (nano), damped by beta 1.42, country premium for South Korea. The same rate applies in all 26 models.
What is a reverse DCF?
A reverse DCF turns the usual calculation around. Instead of deriving a value from assumptions, it takes today's price as given and asks: what free-cash-flow growth would a company have to deliver for exactly this price to be fair? The result is not a forecast but the expectation already priced in. For Innometry Co. Ltd that is +0.5 % per year a year over ten years, using the same discount rate (11.2 %) and the same formula as our fair value.
How much growth has Innometry Co. Ltd (302430) delivered so far?
Over the past 5 years revenue at Innometry Co. Ltd grew +13.2 % a year. The price currently implies +0.5 % per year free-cash-flow growth a year. Comparing the two shows how much confidence is in the price: if it demands more than has been delivered, the business has to accelerate for the maths to work.
How fast is the sector of Innometry Co. Ltd (302430) growing?
The median revenue growth in the sector is +1.8 % a year. That is the yardstick for the growth priced into Innometry Co. Ltd (+0.5 % per year a year): it shows whether the expectation is within the usual range or beyond it.
What is the free cash flow yield of Innometry Co. Ltd (302430)?
The free-cash-flow yield on the price is 6.10 %: that much free cash flow Innometry Co. Ltd produces per unit of market value. When it exceeds the discount rate of our models (11.2 %), the business already earns more than its cost of capital demands, and the price needs little additional growth.
What is the intrinsic value of Innometry Co. Ltd (302430)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Innometry Co. Ltd it is 6,526 KRW per share (as of Sep 24, 2026), against a price of 7,160 KRW. It is the blended result of 7 valuation models (cash flow, earnings, asset, dividend).
Is Innometry Co. Ltd stock overvalued or undervalued in 2026?
As of Sep 24, 2026, 302430 trades above its calculated fair value: price 7,160 KRW, fair value 6,526 KRW, a gap of about −9% (fairly valued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of 302430?
No. The price is what the market pays today (7,160 KRW); the fair value is what the company's own numbers justify (6,526 KRW). For Innometry Co. Ltd the two are 634.31 KRW per share apart. That gap is exactly why we show both numbers side by side.
How much is Innometry Co. Ltd worth?
The market values Innometry Co. Ltd at about 70.4B KRW (market capitalisation, as of Sep 24, 2026). Per share that is 7,160 KRW; our models calculate a fair value of 6,526 KRW per share.
What do the bullish and bearish scenarios say about 302430?
Our models span a range for Innometry Co. Ltd: cautious scenario 4,799 KRW, base 6,526 KRW, optimistic 8,803 KRW per share (as of Sep 24, 2026, price 7,160 KRW). The range comes from different growth and margin assumptions, not from analyst opinions.
How solid is the balance sheet of Innometry Co. Ltd (302430)?
Balance-sheet figures for Innometry Co. Ltd (as of Sep 24, 2026): return on equity −1.8%. They feed the Quality Score of 52/100, which measures business quality independently of the share price.
How far is 302430 from its 52-week high?
Innometry Co. Ltd trades at 7,160 KRW, about 33% below its 52-week high of 10,700 KRW and 70% above the low of 4,220 KRW (as of Sep 23, 2026). Distance from the high says nothing about value: that is what the fair value of 6,526 KRW is for.
Which stocks are comparable to Innometry Co. Ltd?
From the same area (Industrials) we also value GE Vernova Inc, SIE, Eaton Corporation, Parker-Hannifin Corporation, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Innometry Co. Ltd stock attractive at the current price?
The data as of Sep 24, 2026: price 7,160 KRW, calculated fair value 6,526 KRW (−9%), Quality Score 52/100, from 7 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of 302430 calculated?
We run Innometry Co. Ltd through 7 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of 6,526 KRW, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 13.0 % above its aggregate fair value. Innometry Co. Ltd itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Innometry Co. Ltd (302430)?
The closing price on Sep 23, 2026 was 7,160 KRW. Our model-based fair value is 6,526 KRW, about −9% upside (fairly valued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Innometry Co. Ltd right now?
The price sits close to our fair value, market and models broadly agree here, little valuation tension. A fairly wide model range (4,799 KRW to 8,803 KRW) leaves room in how you read the outcome. Evidence is limited here (fewer models, shorter history), so the fair value is a rougher estimate than usual.
Key figures of Innometry Co. Ltd
How large is the market capitalisation of Innometry Co. Ltd (302430)?
The market capitalisation of Innometry Co. Ltd is 70.4B KRW (≈ $51.7M). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Innometry Co. Ltd (302430)?
The price-to-sales ratio of Innometry Co. Ltd is 1.18 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What is the net margin of Innometry Co. Ltd (302430)?
The net margin of Innometry Co. Ltd is −11.1% (fiscal year 2025). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Innometry Co. Ltd (302430)?
The return on equity (ROE) of Innometry Co. Ltd is −1.8% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Innometry Co. Ltd (302430)?
On an EBIT basis the return on assets of Innometry Co. Ltd is 0.3% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Innometry Co. Ltd (302430)?
The operating margin of Innometry Co. Ltd is 1.4% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Innometry Co. Ltd (302430)?
Revenue at Innometry Co. Ltd is growing +102% versus a year earlier (3y avg −20.1%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at Innometry Co. Ltd (302430)?
Earnings per share at Innometry Co. Ltd are growing +6.8% versus a year earlier. How much earnings per share grew versus a year earlier.
Free · no account needed
Watch Innometry Co. Ltd in the live analysis
One click puts Innometry Co. Ltd on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.
